founder & CEO of Renasant Bio
ScienceMachine is a London-based biotech AI startup launching an autonomous agent ('Sam') to streamline biomedical data analysis and visualization for pharma and biotech firms. Founded in 2024, it recently secured $3.5M in seed funding from Revent and Nucleus Capital.